AI-Guided SAR Optimization Strategy and Potent ALDH3A1 Inhibitors

An AI-guided workflow for accelerating drug discovery, developed by Sankalp Jain and last updated in May 2026. The methodology combines reaction-based enumeration, pharmacophore-informed docking, and predictive modeling to optimize structure-activity relationships (SAR). Applied to the target ALDH3A1, it generated about 250,000 virtual analogues and led to a roughly 1,000-fold improvement in biochemical potency.

Use Cases

• Benchmarking AI-guided molecular optimization strategies based on the described reaction-based enumeration and prioritization workflow.
• Developing predictive models for inhibitor potency based on the virtual analogue generation and experimental validation results.
• Exploring scalable SAR expansion strategies for other therapeutic targets based on the generalizable CSAR methodology.

Strengths

• Describes a concrete, validated workflow resulting in a roughly 1,000-fold potency improvement from 1.41 μM to 1 nM.
• Methodology is described as scalable and generalizable, applicable to various chemical reactions and positions.
• Includes specific, named compound results (NCATS-SM0707, NCATS-SM0708) with biochemical and cellular activity data.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small at 17.0 KB, indicating limited scope, likely containing summary results rather than raw experimental data.

Provenance

Source

Sankalp Jain via figshare

Collection Method

AI-guided, reaction-based hit-to-lead workflow combining sequential reaction enumeration, pharmacophore-informed docking, and predictive modeling.

Freshness

Last updated 2026-05-30 14:04:09; freshness should be verified.